Publication | Closed Access

Souers AJ, Leverson JD, Boghaert ER et al.ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 19:202-208

ThrombosisMolecular PharmacologyBlood PlateletNat MedMedicineHematologyImmunologySouers AjPharmacotherapySelective Bcl-2 InhibitorPlatelet AntagonistPharmacologyMolecular Medicine